When.com Web Search

  1. Ads

    related to: car t-cell therapy approved treatment centers list

Search results

  1. Results From The WOW.Com Content Network
  2. Ciltacabtagene autoleucel - Wikipedia

    en.wikipedia.org/wiki/Ciltacabtagene_autoleucel

    The safety and efficacy of ciltacabtagene autoleucel were evaluated in CARTITUDE-1 (NCT03548207), an open label, multicenter clinical trial evaluating ciltacabtagene autoleucel in 97 participants with relapsed or refractory multiple myeloma who received at least three prior lines of therapy which included a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody ...

  3. CAR T cell - Wikipedia

    en.wikipedia.org/wiki/CAR_T_cell

    Depiction of adoptive cell transfer therapy with CAR-engineered T cells. The first step in the production of CAR T-cells is the isolation of T cells from human blood. CAR T-cells may be manufactured either from the patient's own blood, known as an autologous treatment, or from the blood of a healthy donor, known as an allogeneic treatment. The ...

  4. Gene therapy for blood diseases - Wikipedia

    en.wikipedia.org/wiki/Gene_therapy_for_blood...

    The genetically modified T-cells are administered back to the patients as a treatment. Leukemia is a group of blood cancers commonly found in children younger than 15 and elders older than 55. [3] In 2017, tisagenlecleucel (Kymriah™), [2] the first CAR-T cell therapy approved by the FDA, became available to anyone up to the age of 25 with ...

  5. FDA says cancer treatment CAR-T therapy may increase ... - AOL

    www.aol.com/news/fda-says-cancer-treatment-car...

    CAR-T — or chimeric antigen receptor T celltherapy uses a patient’s own immune cells to treat certain blood cancers, such as leukemia, multiple myeloma and lymphoma. It involves ...

  6. List of gene therapies - Wikipedia

    en.wikipedia.org/wiki/List_of_gene_therapies

    Strimvelis: treatment for adenosine deaminase deficiency (ADA-SCID) Talimogene laherparepvec (Imlygic): treatment for melanoma in patients who have recurring skin lesions [17] Tisagenlecleucel (Kymriah): treatment for B cell lymphoblastic leukemia [18] Valoctocogene roxaparvovec (Roctavian): treatment for hemophilia A [19] [20] [21] Voretigene ...

  7. Brexucabtagene autoleucel - Wikipedia

    en.wikipedia.org/wiki/Brexucabtagene_autoleucel

    Brexucabtagene autoleucel, sold under the brand name Tecartus, is a cell-based gene therapy medication for the treatment of mantle cell lymphoma (MCL) [10] [11] [7] and acute lymphoblastic leukemia (ALL). [12] The most common side effects include serious infections, low blood cell counts and a weakened immune system. [10]

  1. Ads

    related to: car t-cell therapy approved treatment centers list